[ad_1] Honored to moderate this very interesting #genetherapy panel discussion, now available via podcast… OIS Podcast Episode #269: KOLs Speak Out on the Future of Gene Therapy https://t.co/nXMnR91Btg via @YouTube [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @ophthopedia: Ophthopedia Update: Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA) https://t.co/EY [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @RetinaToday: In animal models, suprachoroidal injection of axitinib delivered 11x the dose found with intravitreal injection—potentiall…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @EyeVidence: #GeneTherapy for eye diseases are commonly AAV based and delivered subretinal, which is associated with some risk. This stu… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Recently published: Host immune responses after suprachoroidal delivery of AAV8 in nonhuman primate eyes. https://t.co/M1JfUHHFKy “…suprachoroidal AAV delivery of human transgenes may have significant translational potential for retinal gene therapy.”#retina #GeneTherapy #eye [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Honored to have been interviewed on Gene Therapy, by American Society of Retina Specialist’s
@asrsdocs Tim Murray….
#eyes #Ophthalmology #retina #gene #genetherapy
Gene Therapy for Retinal Disease https://t.co/CDezBt3HxD via @YouTube
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @Genes_MDPI: EBM Dr. @ThomasCiullaMD was interviewed by @asrsdocs on gene therapy for retinal diseases: https://t.co/kBJoAJaucP [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Special thanks to Dave Brown who presented “Axitinib: A TKI Delivered by Suprachoroidal Injection for AMD” at Angiogenesis 2021: https://t.co/SMaIJxOvUv via @modernretina [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
OIS Gene Therapy Innovation Showcase 2021 https://t.co/p7FTBuvw25 via @YouTube
A link to the event, if you missed it….
1. Overview
2. A fantastic lineup of presenting companies
3. An expert panel, discussing challenges and differentiating solutions in #retinal #genetherapy
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Please join us on Feb 18 for fascinating discussion on #retina #genetherapy at https://t.co/i8BgpJqY8A We have a fantastic lineup of innovative companies, followed by an intriguing panel discussion with world class experts centered on current challenges & solutions. https://t.co/dGMcOQEJlY [ad_2] Source by Thomas Ciulla, …